News und Analysen
Novavax Posted a Profit in Q2. Here's Why It Doesn't Matter
Novavax (NASDAQ: NVAX) has gone from a pandemic darling to a bust, with its shares falling by a whopping 83% over the past 12 months. The hope and optimism surrounding the stock has faded. Earlier
If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today
UnitedHealth Group (NYSE: UNH) has been a top healthcare stock to own for years. Today, it's among the largest healthcare companies in the world, worth $475 billion. Although it's a health insurer
If You Invested $25,000 in UnitedHealth Stock 10 Years Ago, This Is How Much You Would Have Today
UnitedHealth Group (NYSE: UNH) has been a top healthcare stock to own for years. Today, it's among the largest healthcare companies in the world, worth $475 billion. Although it's a health insurer
2 Excellent Stocks to Buy and Hold Forever
Being a buy-and-hold investor has advantages. For instance, it can be less stressful than day trading, and the combination of time and compounding is a powerful wealth generator. However, with
2 Excellent Stocks to Buy and Hold Forever
Being a buy-and-hold investor has advantages. For instance, it can be less stressful than day trading, and the combination of time and compounding is a powerful wealth generator. However, with
2 Excellent Stocks to Buy and Hold Forever
Being a buy-and-hold investor has advantages. For instance, it can be less stressful than day trading, and the combination of time and compounding is a powerful wealth generator. However, with
1 High-Yield Dividend Stock That Looks Like a Screaming Buy
Pharma giant AbbVie (NYSE: ABBV) performed poorly in the first part of the year, especially after it reported its first-quarter results. This was its first quarterly update following the loss of
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled
Down 15% in 2023, Should You Buy the Dip With Illumina Stock?
Illumina's (NASDAQ: ILMN) stock is down by 15% this year so far, and it's no surprise why. With the new disclosure of a Securities and Exchange Commission (SEC) investigation into its bedraggled
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Why Tilray Brands Stock Is Surging Today
Canada's Tilray Brands (NASDAQ: TLRY) is having a strong trading session today. Specifically, the consumer packaged goods and cannabis company's stock was up by 6.75% on heavy volume as of 1:31 p.m
Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy?
Viatris (NASDAQ: VTRS) could be on the verge of eating the lunch of Novo Nordisk's (NYSE: NVO) two golden cash cows: The diabetes drug Ozempic, and another version that's formulated for weight loss
Viatris Could Soon Make a Generic Ozempic, But Does That Make It a Buy?
Viatris (NASDAQ: VTRS) could be on the verge of eating the lunch of Novo Nordisk's (NYSE: NVO) two golden cash cows: The diabetes drug Ozempic, and another version that's formulated for weight loss
Could Amgen Stock Help You Become a Millionaire?
Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market. Its stock price is up 6.6% in that time, outpacing the 3.2%
Could Amgen Stock Help You Become a Millionaire?
Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market. Its stock price is up 6.6% in that time, outpacing the 3.2%
Could Amgen Stock Help You Become a Millionaire?
Healthcare company Amgen (NASDAQ: AMGN) has been a reliable investment to own over what has been a turbulent year for the broader market. Its stock price is up 6.6% in that time, outpacing the 3.2%
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Should You Buy This Blue Chip Dividend Stock?
Because investing is future-oriented, it is important that investors purchase businesses with ample growth potential in the years ahead. The best way to do this is to only consider investing in
Why Shares of SomaLogic Are Up Tuesday
Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock
Why Shares of SomaLogic Are Up Tuesday
Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock
Why Shares of SomaLogic Are Up Tuesday
Shares of SomaLogic (NASDAQ: SLGC) were up more than 11% as of Tuesday at 11:15 a.m. ET. The biotech company reported second-quarter earnings after the markets closed on Monday. The healthcare stock
Form 8.3 - The Vanguard Group, Inc.: Horizon Therapeutics plc
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think
When a company's revenue and earnings plunge, it's understandable if investors begin to worry about its dividend. Pfizer (NYSE: PFE) reported a 53% year-over-year decline in revenue in its latest
Here's Why Pfizer's High-Yield Dividend Could Be Even Safer Than You Might Think
When a company's revenue and earnings plunge, it's understandable if investors begin to worry about its dividend. Pfizer (NYSE: PFE) reported a 53% year-over-year decline in revenue in its latest